Advertisement

Novel in Vitro Culture and Ultrastructural Techniques to Study the Biology of Myelodysplastic Syndromes (MDS)

  • Sairah Alvi
  • Laurie A. Lisak
  • Vilasini T. Shetty
Part of the Cancer Treatment and Research book series (CTAR, volume 108)

Abstract

MDS is a heterogeneous clonal stem cell disorder with trilineage dysplasia resulting in ineffective, monoclonal hematopoiesis ([Resegotti et al., 1993]). Extensive studies over the decade have led to better understanding of cell proliferation, differentiation, cytokine production and apoptosis in MDS ([Greenburg et al., 1987]; [Shetty et al., 1996]; [Clark et al., 1990]; [Yoshida et al., 1993]; [Raza et al., 1995]). However there has been limited information in the literature regarding long term bone marrow cultures and ultrastructural studies performed on MDS. In the past, it has been difficult to grow MDS bone marrow (BM) cells as the progenitor cells have a great propensity to undergo programmed cell death ([Ohmori et al., 1991]; [Aizawa et al., 1999]; [Raza et al., 1996]). On the other hand the role of electron microscopy has not been clearly established in MDS either, other than few individual cases on BM aspirate because of the failure to overcome the technical impediment of maintaining the ultrastructural details in decalcified tissues ([Guccion et al., 1992]; [Gerrad et al., 1992]; [Cohen et al., 1997]; [Payne et al., 1987]). As a result very little is known about the association between the hematopoietic cells and their microenvironment especially in a disease like MDS where both the parenchymal and stromal cells may be involved in the disease process ([Coutinho et al., 1990]; [Sawada et al., 1998])). The present chapter focuses on novel techniques where primarily the MDS core bone marrow biopsy was used to maintain long term bone marrow cultures followed by ultrastructural studies, hence preserving the BM architecture and the geographical distribution of the hematopoietic and stromal cells as they existin vivo.A number of novel and interesting observations were made which are summarized here.

Keywords

Stromal Cell Myelodysplastic Syndrome Bone Marrow Biopsy Bone Marrow Aspirate Bone Marrow Stroma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aizawa, S., Nakano, M., Iwase, O., Yaguchi, M., Hiramoto, M., Hoshi, H., Nabeshima, R., Shima, D., Banda, H., & Toyama, K, (1999) Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro.Leukemia Research23, 239–246.PubMedCrossRefGoogle Scholar
  2. Alvi, S., Shaher, A., Henderson, B., Dar, S., Zorat, F., Broderick, E., Lisak, L., Du Randt, M., Reddy, P., Mundle, S., Galili, N., Borok, R.Z., & Raza, A, (2000) Improved growth of stromal cells in long term bone marrow cultures (LTBMC) of myelodysplastic syndrome (MDS) patients treated with thalidomide.Blood96, 359a. Abstract #1547.Google Scholar
  3. Bennett, J.M., Catovsky, D., Flandrin, D.M.T., Galton, G.D.A.G., Gralnick, H.R., & Sultan, C., (1982) Proposal for the classification of the myelodysplastic syndromes.British Journal of Haematology51,189–199.PubMedGoogle Scholar
  4. Blazsek, I., Liu, X.H., Anjo, A., Quittet, P., Comisso, M., Kim-Triana, B & Misset, J.L, (1995) The hematon, a morphogenetic functional complex in mammalian bone marrow, involves erythroblastic islands and granulocytic cobblestones.Experimental Hematology23, 309–319.PubMedGoogle Scholar
  5. Bogdanovic, A.D., Jankovic, G.M., Colovic, M.D., Trpinac, D.P., & Bumbasirevic, V.Z, (1996) Apoptosis in bone marrow of myelodysplastic syndrome patients.Blood87, 3064.PubMedGoogle Scholar
  6. Bouscary, D., De Vos, J., Guesnu, M., Jondeau, K., Viguier, F., Melle, J., Picard, F., Dreyfus, F., & Fontenay-Roupie, M, (1997) Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.Leukemia 11839–845.PubMedCrossRefGoogle Scholar
  7. Chang, J., & Dexter, T.M. (1991) Long—term cultures: in vitro purging of leukemic cells.Baillieres Clinical Haematology3:775–788.CrossRefGoogle Scholar
  8. Clark, D.M., & Lampert, I.A., (1990) Apoptosis is a common histopathological finding in myelodysplasia: the correlate of ineffective hematopoiesis.Leukemia Research2, 415–418.Google Scholar
  9. Cohen, A., Alexandrova, S., Kessler, H., Mittelman, M., Cycowitz, Z.&Djaldetti, M, (1997) Ultrastructural observation on bone marrow cells of 26 patients with myelodysplastic syndromes.Leukemia &Lymphoma27, 165–172.Google Scholar
  10. Coutinho, L.H., Geary, C.G., Chang, J., Harrison, C., & Testa, N.G, (1990) Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndromes (MDS).British Journal of Haematology75, 16–25.PubMedCrossRefGoogle Scholar
  11. Davey, F. R., Erber, W. N., & Gatter, K.C., (1988) Abnormal neutrophils in acute leukemia and myelodysplastic syndrome.Human Pathology19, 454–459.PubMedCrossRefGoogle Scholar
  12. Dexter, T.M, (1979) Haemopoiesis in long term bone marrow cultures.Acta Haematologia62, 299–305.CrossRefGoogle Scholar
  13. Diana, C., Dominici, M., Lanza, F., Punturieri, M., Pauli, S., Tieghi, A., Dabusti, M., Scapoli, G., & Castoldi, G, (2000) Impairment of stromal cells compartment in hypoplastic myelodysplastic syndromes.Blood96, 357a. Abstract # 1541.Google Scholar
  14. Duhrsen, U., & Hossfeld, D.K, (1996) Stromal abnormalities in neoplastic bone marrow diseases.Annals ofHematology 7353–70.CrossRefGoogle Scholar
  15. Gerrad, J.M., & McNicol, A, (1992) Platelet storage pool deficiency, leukemia, and myelodysplastic syndromesLeukemia & Lymphoma8, 277–281.CrossRefGoogle Scholar
  16. Gidali, J., Feher, I & Hollan, S.R, (1996) Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.Stem Cells14, 577–583.PubMedCrossRefGoogle Scholar
  17. Greenburg, P.L, (1992) In vitro marrow culture studies in the myelodysplastic syndromes.Seminars in Oncology1, 34–46.Google Scholar
  18. Greenburg, P.L. (1987) Biologic nature of the myelodysplastic syndromes.Acta Haematologica78, 94–99.CrossRefGoogle Scholar
  19. Guccion, J.G., Schechter, G.P., & Zeller, J, (1992) Cytomembranous inclusions in myelodysplastic syndromes.Ultrastructural Pathology16, 521–527.PubMedCrossRefGoogle Scholar
  20. Kouides, P.A., & Bennett, J.M, (1992) Morphology and classification of myelodysplastic syndromes [review].Hematology Oncology Clinics of North America6, 485–499.Google Scholar
  21. Lanotte, M., Allen, T.D., & Dexter, M.T., (1981) Histochemical and ultrastructural characteristics of a cell line from human bone marrow stroma.Journal of Cell Science50, 281–297.PubMedGoogle Scholar
  22. Lai, J.L., & Fenaux, P, (1997) Cytogenetics of myelodysplastic syndromes.Pathological Biology45, 550–555.Google Scholar
  23. Lepelley, P., Campergue, L., Grardel, N., Preudhomme, C., Cosson, A., Fenaux, P, (1996) Is apoptosis a massive process in myelodysplastic syndromes?British Journal of Haematology95, 368–371.PubMedCrossRefGoogle Scholar
  24. Ohmori, M., Ohmori, S., Ueda, Y., Yoshida, Y., & Okuma, M, (1991) Ineffective hematopoiesis in myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony-cluster formation.International Journal of Cell Cloning9, 521–530.PubMedCrossRefGoogle Scholar
  25. Payne, C.M., Greenberg, B., Cromey, D., & Woo, L, (1987) Morphological evidence of an altered bone marrow microenvironment in patients with acute nonlymphoblastic leukemia and myelodysplastic disorders.Experimental. Hematology15, 143–153.PubMedGoogle Scholar
  26. Parcharidou, A., Raza, A., Economopoulos, T., Papageorgiou, E., Anagnostou, D., Papadaki, T., & Raptis, S, (1999) Extensive apoptosis of bone marrow cells as evaluated by in situ end-labeling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes.European Journal of Haematology62, 19–26.PubMedCrossRefGoogle Scholar
  27. Pedersen-Bjergaard, J., Philip, P., Larsen, S.O., Anderson, M., Daugaard, G., Ersboll, J., Hansen, S.W., Hou-Jensen, K., Nielsen, D., Sigsgaard, T.C., Specht, L., & Osterlind, K, (1993) Therapy related myelodysplastic syndromes and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.Leukemia7, 1975–1986.PubMedGoogle Scholar
  28. Polli, N., O’Brien M., Tavares, de., Castro, J., Matutes, E., San Miguel, J.F., & Catovsky, D, (1995) Characterization of blast cells in chronic granulocytic leukemia in transformation, acute myelofibrosis and undifferentiated leukemia. 1. Ultrastructural Morphology and Cytochemistry.British. Journal Haematology59, 277–296.CrossRefGoogle Scholar
  29. Raza, A., Mundle, S., Iftikhar, A., Gregory, S., Marcus, B., Khan, Z., Alvi, S., Shetty, V., Dameron, S., Wright, V., Adler, S., Loew, J., Scott, S., Ali, S.N., & Preisler, H.D., (1995) Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis.American Journal of Hematology48, 143–154.PubMedCrossRefGoogle Scholar
  30. Raza, A., Gezer, S., Mundle, S., Gao, X.Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S., & Preisler, H.D, (1996) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood86, 268–276.Google Scholar
  31. Raza, A., Alvi, S., Borok, R.Z., Span, L., Parcharidou, A., Alston, D., Rifkin, S., Robin, E., Shah, R., & Gregory, S.A, (1997).Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: The cause-effect relationship.Leukemia & Lymphoma27(1–2), 111–118.Google Scholar
  32. Resegotti, L., (1993) The nature and natural history of myelodysplasia.Haematologia25, 191–204.PubMedGoogle Scholar
  33. Sawada, K, (1998) Growth characteristics of myelodysplastic CD34+ cells.Leukemia & Lymphoma„29, 49–60.CrossRefGoogle Scholar
  34. Seed, T.M., Husseini, S.G., & Knospe, W.H, (1986) Hematopoiesis on cellulose ester membranes: VII. Ultrastructure of stroma of marrow enriched membranes with trilineal hematopoiesis.Experimental Hematology14, 108–118.PubMedGoogle Scholar
  35. Shetty, V., Mundle, S, Alvi, S., Showel, M., Broady-Robinson, L., Dar, S., Borok, R., Showel, J., Greagory, S., Rifkin, S., Gezer, S., Parcharidou, A., Venugopal, P., Shah, R., Hernandez, B., Klein, M., Alston, D., Robin, E., Dominguez, C.&Raza, A, (1996) Measurement of apoptosis, proliferation and three cytokine in 46 patients with myelodysplastic syndromes.Leukemia Research20, 891–900.PubMedCrossRefGoogle Scholar
  36. Vallespi, T., Imbert, M., Mecucci, C., Preudhomme, C., & Fenaux, P, (1998) Diagnosis, classification, and cytogenetics of myelodysplastic syndromes.Haematologica83, 258–275.PubMedGoogle Scholar
  37. Verhoef, G.E.G, Pittaluga, S., De Wolf- Peters, C., & Boogaerts, M.A., (1995) FAB classification of myelodysplastic syndromes: merits and controversies.Annals of Hematology71, 3–11.PubMedCrossRefGoogle Scholar
  38. Weimar, I. S., Bourhis, J.H., De Gast, G.C., & Gerritsen, W.R, (1994) Clonality in myelodysplastic syndromes.Leukemia & Lymphoma13, 215–221.CrossRefGoogle Scholar
  39. Weiss, L., (1976) The hematopoietic microenvironment of the bone marrow: An ultrastructural study of the stroma in rat.Anatomica. Records186, 161–184.CrossRefGoogle Scholar
  40. Yoshida, Y., (1993) Apoptosis may be the mechanism responsible for the premature intramedullary cell death in myelodysplastic syndromes.Leukemia7, 144–146.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Sairah Alvi
    • 1
  • Laurie A. Lisak
    • 1
  • Vilasini T. Shetty
    • 1
  1. 1.MDS Center and Section of Myeloid Diseases, Department of MedicineRush UniversityChicago

Personalised recommendations